KEAP1 and neoplasm: Recently, NRF2/KEAP1 mutation or deficiency has been reported to increase tumor metastasis, resistance to oxidative stress in tumor cells [46,47], and recurrence in patients undergoing radiotherapy for lung SCC [48].